The cost of major comorbidity in people with diabetes mellitus
about
The Economic Costs of Type 2 Diabetes: A Global Systematic ReviewQuantification of diabetes comorbidity risks across life using nation-wide big claims dataComorbidity in patients with diabetes mellitus: impact on medical health care utilizationUtilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001Health care utilization and costs in Saskatchewan's registered Indian population with diabetes.Direct costs associated with chronic kidney disease among type 2 diabetic patients in India.Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims databaseRates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics.Patterns of engagement with the health care system and risk of subsequent hospitalization amongst patients with diabetes.Enrolment in primary care networks: impact on outcomes and processes of care for patients with diabetesCost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City.Honey--a novel antidiabetic agent.Use of chronic disease management programs for diabetes: in Alberta's primary care networks.Health care costs in people with diabetes and their association with glycemic control and kidney function.Association of enrolment in primary care networks with diabetes care and outcomes among First Nations and low-income Albertans.Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis.Lifetime risk of diabetes among First Nations and non-First Nations people.Identifying strategies to improve diabetes care in Alberta, Canada, using the knowledge-to-action cycle.Canadian residential schools and urban indigenous knowledge production about diabetes.The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction modelProjecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey.
P2860
Q28087120-D72F6740-6482-4E17-A881-8C06F1DB99C9Q30927990-A94944E4-75BB-4B0E-A19F-EA363D661EB0Q33248806-9946B3B0-1C53-4717-AB58-5E45BB2ADFE6Q33266312-89E6256E-51AD-4E13-8620-9512EA9FB717Q33294094-F4BCD940-5FD0-400B-967E-6456AD05225DQ34024303-71E2753F-E824-4ECE-B05A-2BA4C73E2A2CQ34353022-771420C3-7997-4135-8E54-B16FBEDCCC1EQ34422037-24358ABE-717E-4B88-9F7F-79D6538843F8Q34425300-ADAB1FB5-A9A1-4049-9216-D32271570A46Q34550144-0429824C-D013-441F-AF3F-69C6ECA4A1ADQ34804878-81D8EF64-BE1E-492E-9C76-AB23000A3D57Q35011042-3A17AD1E-FE86-4DF9-9CDB-277FCE0BA321Q35739919-4845A808-0F93-4D92-BA14-9A1EAD300DF8Q35832130-C6A49801-C9B9-4E94-8FB0-681D94CDC681Q36101651-AA3E8A97-CEBF-4975-A1DE-2F91F1C236ECQ36623164-35A0903D-687E-4BA7-A8FF-23DF62A605DAQ36782623-0A2344DC-1F4C-449B-8241-8BD224DB377EQ36845586-51A84616-5452-4332-821F-B169B7C6C17BQ37238328-A2330DA6-4326-42B2-991F-9A33A945AE7DQ37382052-851E592C-FDB8-4689-9A59-35DBC44C4530Q37701703-E79E9574-C4E6-4BD9-9049-998A0CC4F891Q37702481-35F46735-4A41-4CA8-8A9F-B6E3396C4FCBQ38748819-B1AC46B0-1BA4-4737-9E3D-ABBEF6ACDB83Q40058808-FA44A318-52FD-496E-81B0-6544B54A5ABEQ40165344-6FF4AEF9-A267-40CB-A41E-A6D7C7F7A11A
P2860
The cost of major comorbidity in people with diabetes mellitus
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The cost of major comorbidity in people with diabetes mellitus
@ast
The cost of major comorbidity in people with diabetes mellitus
@en
type
label
The cost of major comorbidity in people with diabetes mellitus
@ast
The cost of major comorbidity in people with diabetes mellitus
@en
prefLabel
The cost of major comorbidity in people with diabetes mellitus
@ast
The cost of major comorbidity in people with diabetes mellitus
@en
P2093
P2860
P1476
The cost of major comorbidity in people with diabetes mellitus
@en
P2093
Jeffrey A Johnson
Paula Corabian
Philip Jacobs
Scot H Simpson
P2860
P304
P407
P577
2003-06-01T00:00:00Z